-
Something wrong with this record ?
Identification of metabolic changes leading to cancer susceptibility in Fanconi anemia cells
E. Abad, S. Samino, RL. Grodzicki, G. Pagano, M. Trifuoggi, D. Graifer, D. Potesil, Z. Zdrahal, O. Yanes, A. Lyakhovich
Language English Country Ireland
Document type Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- Cell Line MeSH
- Chromatography, Liquid MeSH
- Fanconi Anemia metabolism MeSH
- Glycolysis MeSH
- Humans MeSH
- Metabolic Networks and Pathways * MeSH
- Metabolomics methods MeSH
- DNA Repair MeSH
- Oxidative Phosphorylation MeSH
- Proteomics methods MeSH
- Tandem Mass Spectrometry MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
Fanconi anemia (FA) is a chromosomal instability disorder of bone marrow associated with aplastic anemia, congenital abnormalities and a high risk of malignancies. The identification of more than two dozen FA genes has revealed a plethora of interacting proteins that are mainly involved in repair of DNA interstrand crosslinks (ICLs). Other important findings associated with FA are inflammation, oxidative stress response, mitochondrial dysfunction and mitophagy. In this work, we performed quantitative proteomic and metabolomic analyses on defective FA cells and identified a number of metabolic abnormalities associated with cancer. In particular, an increased de novo purine biosynthesis, a high concentration of fumarate, and an accumulation of purinosomal clusters were found. This was in parallel with decreased OXPHOS and altered glycolysis. On the whole, our results indicate an association between the need for nitrogenous bases upon impaired DDR in FA cells with a subsequent increase in purine metabolism and a potential role in oncogenesis.
Biosfer Teslab SL Reus Tarragona Spain
CEITEC Central European Institute of Technology Masaryk University Brno Czech Republic
Department of Chemical Sciences Federico 2 Naples University 1 80126 Naples Italy
Department of Experimental and Health Sciences Universitat Pompeu Fabra Barcelona Spain
Novosibirsk State University Russian Federation
Universitat Rovira i Virgili Department of Electronic Engineering IISPV Tarragona 43007 Spain
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21025854
- 003
- CZ-PrNML
- 005
- 20211026133439.0
- 007
- ta
- 008
- 211013s2021 ie f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.canlet.2020.12.010 $2 doi
- 035 __
- $a (PubMed)33316348
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ie
- 100 1_
- $a Abad, Etna $u Department of Experimental and Health Sciences, Universitat Pompeu Fabra, Barcelona, Spain
- 245 10
- $a Identification of metabolic changes leading to cancer susceptibility in Fanconi anemia cells / $c E. Abad, S. Samino, RL. Grodzicki, G. Pagano, M. Trifuoggi, D. Graifer, D. Potesil, Z. Zdrahal, O. Yanes, A. Lyakhovich
- 520 9_
- $a Fanconi anemia (FA) is a chromosomal instability disorder of bone marrow associated with aplastic anemia, congenital abnormalities and a high risk of malignancies. The identification of more than two dozen FA genes has revealed a plethora of interacting proteins that are mainly involved in repair of DNA interstrand crosslinks (ICLs). Other important findings associated with FA are inflammation, oxidative stress response, mitochondrial dysfunction and mitophagy. In this work, we performed quantitative proteomic and metabolomic analyses on defective FA cells and identified a number of metabolic abnormalities associated with cancer. In particular, an increased de novo purine biosynthesis, a high concentration of fumarate, and an accumulation of purinosomal clusters were found. This was in parallel with decreased OXPHOS and altered glycolysis. On the whole, our results indicate an association between the need for nitrogenous bases upon impaired DDR in FA cells with a subsequent increase in purine metabolism and a potential role in oncogenesis.
- 650 _2
- $a buněčné linie $7 D002460
- 650 _2
- $a chromatografie kapalinová $7 D002853
- 650 _2
- $a oprava DNA $7 D004260
- 650 _2
- $a Fanconiho anemie $x metabolismus $7 D005199
- 650 _2
- $a glykolýza $7 D006019
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a metabolické sítě a dráhy $7 D053858
- 650 _2
- $a metabolomika $x metody $7 D055432
- 650 _2
- $a oxidativní fosforylace $7 D010085
- 650 _2
- $a proteomika $x metody $7 D040901
- 650 _2
- $a tandemová hmotnostní spektrometrie $7 D053719
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Samino, Sara $u Biosfer Teslab SL, Reus, Tarragona, Spain
- 700 1_
- $a Grodzicki, Robert L $u Yale School of Medicine, Yale University, New Haven, CT, USA
- 700 1_
- $a Pagano, Giovanni $u Department of Chemical Sciences, Federico II Naples University, I-80126 Naples, Italy
- 700 1_
- $a Trifuoggi, Marco $u Department of Chemical Sciences, Federico II Naples University, I-80126 Naples, Italy
- 700 1_
- $a Graifer, Dmitry $u Novosibirsk State University, Russian Federation
- 700 1_
- $a Potesil, David $u CEITEC - Central European Institute of Technology, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Zdrahal, Zbynek $u CEITEC - Central European Institute of Technology, Masaryk University, Brno, Czech Republic; National Centre for Biomolecular Research, Faculty of Science, Masaryk University, Kamenice 5, 62500 Brno, Czech Republic
- 700 1_
- $a Yanes, Oscar $u Universitat Rovira i Virgili, Department of Electronic Engineering, IISPV, Tarragona 43007, Spain; CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid 28029, Spain
- 700 1_
- $a Lyakhovich, Alex $u Institute of Molecular Biology and Biophysics, Federal Research Center of Fundamental and Translational Medicine, Novosibirsk, 630117, Russia; Vall D'Hebron Institut de Recerca, 08035, Barcelona, Spain. Electronic address: alex.lyakhovich@mail.muni.cz
- 773 0_
- $w MED00001044 $t Cancer letters $x 1872-7980 $g Roč. 503, č. - (2021), s. 185-196
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33316348 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20211013 $b ABA008
- 991 __
- $a 20211026133445 $b ABA008
- 999 __
- $a ok $b bmc $g 1714761 $s 1146361
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 503 $c - $d 185-196 $e 20201211 $i 1872-7980 $m Cancer letters $n Cancer Lett $x MED00001044
- LZP __
- $a Pubmed-20211013